1. World Health Organization
28 October, 2019
Countries using and
planning to introduce IPV
and the global status of
bOPV registration

2. Countries using and planning to introduce IPV June 2016 status report
World Health Organization
28 October 2019
Countries using and planning to introduce IPV June 2016 status report
This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV).
It also includes a summary of the global status of national registration of bivalent Oral Polio Vaccine (bOPV), in preparation for the switch from trivalent OPV (tOPV) to bOPV.
Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact with any questions or updates on this data.
Definitions
Formal decision to introduce: The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for Gavi eligible countries, a complete application for IPV has been submitted to the Gavi Secretariat.
Tracking these decisions and informal intents provide an indication of the global trend towards meeting the targets of the Polio Eradication and Endgame Strategic Plan.

3. Countries using IPV vaccine to date and formal decision to introduce
World Health Organization
Countries using IPV vaccine to date and formal decision to introduce
28 October, 2019
Introduced to date
Afghanistan Albania Algeria Andorra Antigua and Barbuda Argentina Australia Austria Azerbaijan Bahamas (the) Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burundi Cambodia Cameroon Canada Central African Republic (the) Chad Chile China Colombia Comoros (the) Congo (the) Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic (the) Denmark Djibouti Dominica Dominican Republic (the) DPR Korea DR Congo Ecuador El Salvador Estonia Ethiopia Fiji Finland France Gabon Gambia (the) Georgia Germany Greece Grenada Guatemala Guinea Guyana Haiti Honduras Hungary Iceland India Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Lao People's Democratic Republic (the) Latvia Lebanon Lesotho Libya Lithuania Luxembourg Madagascar Malaysia Maldives Mali Malta Marshall Islands (the) Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands (the) New Zealand Nicaragua Niger (the) Nigeria Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Poland Portugal Qatar Rep of Korea Romania Russian Federation (the) Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan (the) Suriname Sweden Switzerland Syrian Arab Republic (the) Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Trinidad and Tobago Tunisia Turkey Tuvalu Uganda Ukraine United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United States of America (the) Uruguay Vanuatu Venezuela (Bolivarian Republic of) Yemen
Formal commitment to introduce in 2016
Armenia Cabo Verde Equatorial Guinea Guinea-Bissau Indonesia Swaziland
Introduction delayed to 2017
Angola Burkina Faso Egypt Eritrea Ghana Kyrgyzstan Liberia Malawi Mongolia Republic of Moldova (the) Rwanda Sierra Leone Tajikistan Togo Turkmenistan United Republic of Tanzania (the) Uzbekistan Viet Nam Zambia Zimbabwe
Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, St Kitts & Nevis, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015); Cuba, El Salvador, Guatemala, Haiti, Iraq & Venezuela (Bolivian Rep of) (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Chile & Mali (March 2016); Argentina, Congo, Djibouti, Lesotho, Sao Tome & P., Uganda (April 2016)
Introduced to date*
(168 countries or 87%)
Formal commitment to introduce in 2016
(6 countries or 3%)
Introduction delayed in 2017
(20 countries or 10%)
Not available
Not applicable
Data source: WHO/IVB Database, as of 01 June 2016
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
* Including partial introduction in India
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 1 June 2016

4. World Health Organization
Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status
World Health Organization
28 October, 2019
Introduced to date
Afghanistan Albania Algeria Andorra Antigua and Barbuda Argentina Australia Austria Azerbaijan Bahamas (the) Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burundi Cambodia Cameroon Canada Central African Republic (the) Chad Chile China Colombia Comoros (the) Congo (the) Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic (the) Denmark Djibouti Dominica Dominican Republic (the) DPR Korea DR Congo Ecuador El Salvador Estonia Ethiopia Fiji Finland France Gabon Gambia (the) Georgia Germany Greece Grenada Guatemala Guinea Guyana Haiti Honduras Hungary Iceland India Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Lao People's Democratic Republic (the) Latvia Lebanon Lesotho Libya Lithuania Luxembourg Madagascar Malaysia Maldives Mali Malta Marshall Islands (the) Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands (the) New Zealand Nicaragua Niger (the) Nigeria Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Poland Portugal Qatar Rep of Korea Romania Russian Federation (the) Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan (the) Suriname Sweden Switzerland Syrian Arab Republic (the) Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Trinidad and Tobago Tunisia Turkey Tuvalu Uganda Ukraine United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United States of America (the) Uruguay Vanuatu Venezuela (Bolivarian Republic of) Yemen
Gavi countries with formal commitment to introduce in
Angola Armenia Burkina Faso Eritrea Ghana Guinea-Bissau Indonesia Kyrgyzstan Liberia Malawi Mongolia Republic of Moldova (the) Rwanda Sierra Leone Tajikistan Togo United Republic of Tanzania (the) Uzbekistan Viet Nam Zambia Zimbabwe
Non Gavi countries with formal commitment to introduce in
Cabo Verde, Egypt, Equatorial Guinea, Swaziland, Turkmenistan
Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, St Kitts & Nevis, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015); Cuba, El Salvador, Guatemala, Haiti, Iraq & Venezuela (Bolivian Rep of) (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Chile & Mali (March 2016); Argentina, Congo, Djibouti, Lesotho, Sao Tome & P., Uganda (April 2016)
Introduced to date*
(168 countries or 87%)
Gavi countries with formal commitment to introduce in
(21 countries or 10%)
Non Gavi countries with formal commitment to introduce in
(5 countries or 3%)
Not available
Data source: WHO/IVB Database, as of 01 June 2016
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Not applicable
* Including partial introduction in India
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 1 June 2016

5. 26 countries introducing IPV between 1 June 2016 and December 2017
World Health Organization
26 countries introducing IPV between 1 June 2016 and December 2017
28 October, 2019
June – July 2016
December 2017
Armenia
Angola
Cabo Verde
Burkina Faso
Equatorial Guinea
Egypt
Guinea-Bissau
Eritrea
Indonesia
Ghana
Swaziland
Kyrgyzstan
Liberia
Malawi
Mongolia
Rep. of Moldova
Rwanda
Sierra Leone
Tajikistan
Togo
Turkmenistan
United Rep. of Tanzania
Uzbekistan
Viet Nam
Zambia
Zimbabwe 6 20
Legend
Tier 2 countries
Data source: WHO/IVB Database, as of 01 June 2016
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries
Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC

6. World Health Organization
Tier 1 and 2 Countries using IPV vaccine to date and formal decision to introduce
28 October, 2019
Introduction to date
Afghanistan Azerbaijan Benin Cambodia Cameroon Central African Republic (the) Chad China Congo (the) Dominican Republic (the) DR Congo Ethiopia Gabon Guinea Haiti India Iraq Kenya Lao People's Democratic Republic (the) Madagascar Mali Mauritania Mozambique Myanmar Niger (the) Nigeria Pakistan Papua New Guinea Philippines (the) Somalia South Sudan Timor-Leste Uganda Yemen
Formal commitment to introduce in
Equatorial Guinea, Indonesia
Not Applicable or not Tier 1 or 2 countries
Angola, Albania, Andorra, United Arab Emirates (the), Argentina, Armenia, Antigua and Barbuda, Australia, Austria, Burundi, Belgium, Burkina Faso, Bangladesh, Bulgaria, Bahrain, Bahamas (the), Bosnia and Herzegovina, Belarus, Belize, Bolivia (Plurinational State of), Brazil, Barbados, Brunei Darussalam, Bhutan, Botswana, Canada, Switzerland, Chile, Cote d'Ivoire, Cook Islands, Colombia, Comoros (the), Cabo Verde, Costa Rica, Cuba, Cyprus, Czech Republic (the), Germany, Djibouti, Dominica, Denmark, Algeria, Ecuador, Egypt, Eritrea, Spain, Estonia, Finland, Fiji, France, Micronesia (Federated States of), United Kingdom of Great Britain and Northern Ireland (the), Georgia, Ghana, Gambia (the), Guinea-Bissau, Greece, Grenada, Guatemala, Guyana, Honduras, Croatia, Hungary, Ireland, Iran (Islamic Republic of), Iceland, Israel, Italy, Jamaica, Jordan, Japan, Kazakhstan, Kyrgyzstan, Kiribati, Saint Kitts and Nevis, Rep of Korea, Kuwait, Lebanon, Liberia, Libya, Saint Lucia, Sri Lanka, Lesotho, Lithuania, Luxembourg, Latvia, Morocco, Monaco, Republic of Moldova (the), Maldives, Mexico, Marshall Islands (the), The former Yugoslav Republic of Macedonia, Malta, Montenegro, Mongolia, Mauritius, Malawi, Malaysia, Namibia, Nicaragua, Niue, Netherlands (the), Norway, Nepal, Nauru, New Zealand, Oman, Panama, Peru, Palau, Poland, DPR Korea, Portugal, Paraguay, Qatar, Romania, Russian Federation (the), Rwanda, Saudi Arabia, Sudan (the), Senegal, Singapore, Solomon Islands, Sierra Leone, El Salvador, San Marino, Serbia, Sao Tome and Principe, Suriname, Slovakia, Slovenia, Sweden, Swaziland, Seychelles, Syrian Arab Republic (the), Togo, Thailand, Tajikistan, Turkmenistan, Tonga, Trinidad and Tobago, Tunisia, Turkey, Tuvalu, United Republic of Tanzania (the), Ukraine, Uruguay, United States of America (the), Uzbekistan, Saint Vincent and the Grenadines, Venezuela (Bolivarian Republic of), Viet Nam, Vanuatu, Samoa, South Africa, Zambia, Zimbabwe
Since January 2013, the following Tier 1 and 2 countries have introduced IPV:
The Philippines (October 2014), China (December 2014), Nigeria (February 2015), DR Congo (April 2015), Madagascar (May 2015), Cameroon, Niger and Pakistan (July 2015); Benin, Chad and Papua New Guinea (August 2015); Afghanistan and CAR (September 2015); Lao People's Democratic Republic (October 2015); Guinea, India, Mauritania, Mozambique, Somalia & Yemen (November 2015); Cambodia, Dominican Rep., Ethiopia, Gabon, Kenya, Myanmar & S. Sudan (December 2015); Haiti & Iraq (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Mali (March 2016); Congo & Uganda (April 2016)
Introduced to date*
(34 countries or 94%)
Formal commitment to introduce in 2016
(2 countries or 6%)
Not applicable / not available / not Tier 1 or 2 countries
* Including partial introduction in India
Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries
Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries
with DTP3 coverage <80% in the past 3 years as per WUENIC
Data source: WHO/IVB Database, as of 01 June 2016,
based on 36 tier 1 & 2 countries
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 1 June 2016

7. World Health Organization
Middle Income Countries using IPV vaccine to date and formal decision to introduce
28 October, 2019
Introduced to date
Albania Algeria Azerbaijan Bangladesh Belarus Belize Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Bulgaria Cameroon China Colombia Congo (the) Costa Rica Cote d'Ivoire Cuba Djibouti Dominica Dominican Republic (the) Ecuador El Salvador Fiji Gabon Georgia Grenada Guatemala Guyana Honduras India Iran (Islamic Republic of) Iraq Jamaica Jordan Kazakhstan Kenya Kiribati Lao People's Democratic Republic (the) Lebanon Lesotho Libya Malaysia Maldives Marshall Islands (the) Mauritania Mauritius Mexico Micronesia (Federated States of) Montenegro Morocco Myanmar Namibia Nicaragua Nigeria Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Romania Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Senegal Serbia Solomon Islands South Africa Sri Lanka Sudan (the) Suriname Syrian Arab Republic (the) Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Tunisia Turkey Tuvalu Ukraine Vanuatu Yemen
Formal commitment to introduce in
Angola Armenia Cabo Verde Egypt Ghana Indonesia Kyrgyzstan Mongolia Republic of Moldova (the) Swaziland Tajikistan Turkmenistan Uzbekistan Viet Nam Zambia
Since January 2013, the following MIC have introduced IPV: Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May ); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015); Maldives (March 2015) and Cote d'Ivoire, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Pakistan & Sri Lanka (July 2015); Papua New Guinea & the former Yugoslav Rep. of Macedonia (August 2015); Dominica, Guyana, Iran, Jamaica & Solomon Islands (September 2015); Lao People's Democratic Rep & Samoa (October 2015); Botswana, India, Mauritania, Mauritius, Namibia, Nicaragua, St Lucia, Tuvalu , Vanuatu & Yemen (November 2015); Algeria, Belize, Dominican Rep, Ecuador, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, Thailand & Tonga (December 2015); Cuba, El Salvador, Iraq & Guatemala (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Congo, Djibouti, Lesotho & Sao Tome & P. (April 2016)
Introduced to date
(86 countries or 85%)
Formal commitment to introduce in
(15 countries or 15%)
Data source: WHO/IVB Database, as of 01 June 2016 based on 101
middle income countries (MIC) as per last World Bank classification
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Not applicable / not available / Not introduced / Non MIC
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 1 June 2016

8. World Health Organization
28 October, 2019
Overview of Global birth cohort by IPV status/tier (100% = million births in 2016)
* Partial Introduction
Data source: WHO/IVB Database, as of 01 June 2016 and United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision

9. bOPV registration status for routine immunization
World Health Organization
28 October, 2019
Approval for use
Afghanistan, Albania, Algeria, Angola, Antigua and Barbuda, Argentina, Armenia, Azerbaijan, Bahamas (the), Bahrain, Bangladesh, Barbados, Belize, Benin, Bhutan, Bolivia (Plurinational State of), Bosnia and Herzegovina, Botswana, Brazil, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African Republic (the), Chile, China, Colombia, Comoros (the), Congo (the), Cook Islands, Cote d'Ivoire, Djibouti, Dominica, Dominican Republic (the), DPR Korea, DR Congo, Ecuador, Egypt, El Salvador, Equatorial Guinea, Fiji, Gabon, Gambia (the), Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, India, Indonesia, Iran (Islamic Republic of), Iraq, Israel, Jamaica, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Lao People's Democratic Republic (the), Lebanon, Lesotho, Liberia, Libya, Madagascar, Malawi, Maldives, Mali, Mauritius, Mongolia, Myanmar, Nauru, Nepal, Nicaragua, Niger (the), Nigeria, Oman, Pakistan, Panama, Papua New Guinea, Paraguay, Peru, Philippines (the), Republic of Moldova (the), Russian Federation (the), Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Saudi Arabia, Serbia, Seychelles, Sierra Leone, Singapore, Solomon Islands, Somalia, South Africa, South Sudan, Sri Lanka, Sudan (the), Suriname, Swaziland, Syrian Arab Republic (the), Tajikistan, Thailand, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Trinidad and Tobago, Turkmenistan, Ukraine, United Arab Emirates (the), Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen
Review in progress
Mexico
Approval for use
(143 countries )
Review in progress
(1 country - Mexico)
Data source: WHO/IVB Database, as of 01 June 2016
based on 148 OPV user countries and 7 Territories
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Not available/ non switch countries
(46 countries) + 4 countries switching from tOPV to IPV
Not applicable (switch area territories)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 1 June 2016